Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
20/12/2025
Statement shows: The Italian Gold Goose Group welcomes the Swiss Peak Group as the majority shareholder, with Temasek as a minority shareholder.
Latest
4 m ago
Sanofi: Will reduce the prices of certain drugs used in the United States to treat diabetes, cardiovascular and neurological diseases, as well as cancer by an average of 61%.
4 m ago
American President Trump: Tariff threats force pharmaceutical companies to reach agreements.
4 m ago
Amgen: Working with the US government to take action to lower the cost of drugs for American patients. Since 2018, Amgen has invested over $40 billion in manufacturing and research and development. It will expand its "direct-to-patient" program AmgenNow to include Aimovig and Amjevita. All three drugs will also be available through TRUMPRX.GOV. Aimovig and Amjevita will be offered at a discounted price of $299 per month.
4 m ago
Aimovig and Amjevita will be offered at a discounted price of $299 per month. The "Direct-to-Patient" program AmgenNow will be expanded to include Aimovig (erenumab-aooe) and Amjevita (adalimumab-atto). All three drugs will also be available through TRUMPRX.GOV. Working with the U.S. government to take action to lower drug costs for American patients. Amgen has invested over $40 billion in manufacturing and research and development since 2018.
5 m ago
The US Department of the Treasury has extended the license protecting CITGO Petroleum Corporation, a subsidiary of Chevron, from creditors' claims until February 3, 2026.
See all latest